文献速递颈动脉与弓上血管

开放与闭合单元支架在经股动脉颈动脉支架术中的比较:目标试验模拟

Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation.
PubMed 文献 · J Vasc Surg · 2026-07-14

本研究通过三中心回顾性目标试验模拟,比较开放单元支架(OCS)与闭合单元支架(CCS)在颈动脉分叉病变经股动脉支架术中的结局。纳入1024例患者,中位随访26.0个月,加权后显示CCS与更高的支架内再狭窄(ISR)及复发TIA风险相关,围术期不良事件无显著差异。结论支持在颈动脉分叉处优先考虑OCS以获得长期通畅性。

要点

  • CCS与更高的ISR、严重ISR、症状性ISR及复发TIA风险独立相关。
  • 围术期不良事件在OCS与CCS组间无显著差异。
  • 颈动脉分叉病变长期通畅性支持优先选择OCS。

核心结论

  • 与CCS相比,OCS与更低的再狭窄风险相关,且围术期结局无实质差异。
  • 研究结果支持在颈动脉分叉处优先考虑OCS以维持长期通畅性。

研究设计与样本

  • 回顾性目标试验模拟,使用三个中心的数据。
  • 纳入连续接受经股动脉颈动脉支架术并使用栓塞保护装置的动脉粥样硬化性颈动脉分叉病变患者,按支架设计分组。
  • 共纳入1024例患者,其中577例接受OCS,447例接受CCS;524例(51.2%)有症状,500例(48.8%)无症状。
  • 采用稳定化逆概率治疗加权平衡基线协变量,中位随访26.0个月(四分位距19.4-32.4个月)。

主要发现

  • 围术期不良事件在两组间无显著差异。

临床怎么用

  • 对于颈动脉分叉病变行经股动脉支架术,可优先考虑OCS以降低长期再狭窄风险。
  • CCS可能在需要更密集斑块覆盖的不稳定斑块中保留理论优势。

局限性

  • 回顾性目标试验模拟设计可能存在残余混杂。
  • 随访时间中位数26.0个月,长期结局需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The comparative association of open-cell stent (OCS) and closed-cell stent (CCS) design with outcomes after protected transfemoral carotid artery stenting, particularly long-term patency, remains uncertain. This study compared OCSs and CCSs in patients with carotid bifurcation disease. METHODS: We retrospectively emulated a target trial using data from three centers. Consecutive patients who underwent transfemoral carotid artery stenting with embolic protection devices for atherosclerotic carotid bifurcation lesions were included and classified according to stent design. Stabilized inverse probability of treatment weighting was used to balance baseline covariates. Periprocedural outcomes were assessed within 30 days. Follow-up outcomes included in-stent restenosis (ISR), severe ISR, symptomatic ISR, recurrent ipsilateral ischemic events (stroke or transient ischemic attack), and target-vessel revascularization. RESULTS: Among 1024 patients, 524 (51.2%) were symptomatic and 500 (48.8%) were asymptomatic; 577 received OCSs and 447 received CCSs. Median follow-up was 26.0 months (interquartile range, 19.4-32.4 months). After inverse probability of treatment weighting, baseline covariates were well balanced. Periprocedural adverse events did not differ significantly between groups. During follow-up, CCS use was associated with higher risks of ISR (hazard ratio [HR], 1.66; 95% confidence interval [CI], 1.19-2.31; P = .003), severe ISR (HR, 1.61; 95% CI, 1.06-2.45; P = .026), symptomatic ISR (HR, 2.03; 95% CI, 1.20-3.45; P = .008), and recurrent transient ischemic attack (HR, 3.06; 95% CI, 1.24-7.55; P = .015). Any ISR and severe ISR were strongly associated with recurrent ipsilateral ischemic events (both P < .001). CCS use appeared more strongly associated with ISR in symptomatic patients, without significant interaction by symptom status (P for interaction = .206). Sensitivity analyses were concordant with the primary results. CONCLUSIONS: OCSs were associated with a lower hazard of restenosis and no material difference in periprocedural outcomes compared with CCSs. These findings support preferential consideration of OCSs at the carotid bifurcation for long-term patency, whereas CCSs may retain a theoretical advantage in unstable plaques requiring denser plaque coverage.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang Z, Sun X, Zhong K, et al. Open- versus closed-cell stents in transfemoral carotid artery stenting for carotid bifurcation disease: a target trial emulation. J Vasc Surg. 2026. PMID: 42448157. doi:10.1016/j.jvs.2026.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。